Are you over 18 and want to see adult content?
More Annotations
![The Cook's Pyjamas - Real Food for Busy People](https://www.archivebay.com/archive/817456aa-1703-4ee7-a0ab-9758aa7681e3.png)
The Cook's Pyjamas - Real Food for Busy People
Are you over 18 and want to see adult content?
![Дошкільний навчальний заклад №3 - ДНЗ №3](https://www.archivebay.com/archive/4ac5a5f2-1d1a-471c-b63d-397dbee748d7.png)
Дошкільний навчальний заклад №3 - ДНЗ №3
Are you over 18 and want to see adult content?
![CAMERA on Campus | Get the facts. Get Israel.](https://www.archivebay.com/archive/879356f1-accf-416b-9133-fccf43247453.png)
CAMERA on Campus | Get the facts. Get Israel.
Are you over 18 and want to see adult content?
![Alan J. Hogan: Web Developer, Mac user, and more | AlanHogan.com](https://www.archivebay.com/archive/cee244d8-f321-4101-af8d-aa15e611eeda.png)
Alan J. Hogan: Web Developer, Mac user, and more | AlanHogan.com
Are you over 18 and want to see adult content?
Favourite Annotations
![A complete backup of https://marrymag.de](https://www.archivebay.com/archive6/images/5a1b061c-a5a0-43d7-a632-57429d8beeca.png)
A complete backup of https://marrymag.de
Are you over 18 and want to see adult content?
![A complete backup of https://mbemag.com](https://www.archivebay.com/archive6/images/9f7c181a-54c5-453b-8d65-aa18225942de.png)
A complete backup of https://mbemag.com
Are you over 18 and want to see adult content?
![A complete backup of https://paykrs.in](https://www.archivebay.com/archive6/images/2734909d-ade6-4233-aa8b-8b58ced38915.png)
A complete backup of https://paykrs.in
Are you over 18 and want to see adult content?
![A complete backup of https://calamigos.com](https://www.archivebay.com/archive6/images/1794dca5-7657-4d22-a0fa-1feeb819fe6e.png)
A complete backup of https://calamigos.com
Are you over 18 and want to see adult content?
![A complete backup of https://sandcountyfoundation.org](https://www.archivebay.com/archive6/images/ac5ed2f2-835d-4380-9f8f-ae8d6dacbe58.png)
A complete backup of https://sandcountyfoundation.org
Are you over 18 and want to see adult content?
![A complete backup of https://deximaging.com](https://www.archivebay.com/archive6/images/bcb15318-3952-4e2f-aebe-0a24509e0797.png)
A complete backup of https://deximaging.com
Are you over 18 and want to see adult content?
![A complete backup of https://westfieldnj.biz](https://www.archivebay.com/archive6/images/ae739306-d73b-40af-832e-0887fb514034.png)
A complete backup of https://westfieldnj.biz
Are you over 18 and want to see adult content?
![A complete backup of https://ptvsports.su](https://www.archivebay.com/archive6/images/18c4c715-4f61-447a-8a31-0c0ce2f39c93.png)
A complete backup of https://ptvsports.su
Are you over 18 and want to see adult content?
![A complete backup of https://platron.ru](https://www.archivebay.com/archive6/images/484002e2-9883-4f7d-843a-f54d59123240.png)
A complete backup of https://platron.ru
Are you over 18 and want to see adult content?
![A complete backup of https://industrialmetalsupply.com](https://www.archivebay.com/archive6/images/e94b046d-7293-4dc4-89e0-68e910ad95c9.png)
A complete backup of https://industrialmetalsupply.com
Are you over 18 and want to see adult content?
![A complete backup of https://sterlingbankng.com](https://www.archivebay.com/archive6/images/7eee9bc1-187a-4626-854f-bfbf22acff79.png)
A complete backup of https://sterlingbankng.com
Are you over 18 and want to see adult content?
Text
customer-centric.
EVERYTHING YOU NEED TO KNOW ABOUT THE CHANGING MEDICAL The expert panel of contributors includes: Dr Ameet Nathwani, Chief Medical Officer, Sanofi Antonio Tataranni, SVP and Head of Medical Affairs, Sanofi Danie Du Plessis, Head of Medical Affairs, GlaxoSmithKline Gundula Schneidewind, VP, Medical Affairs, Takeda Michael Zaiac, Head of Medical Affairs, Celgene Mark Rees Saunders, MSL Excellence Lead, AstraZeneca DOWNLOAD YOUR FREE COPY OF THE WHITE PAPER HERE! Medical Affairs is undergoing a revolution. A new Medical model is therefore top priority across pharma’s leadership. With the help of Allergan, Takeda, Roche, Eisai, Ipsen and many more our latest white paper explores the newest approaches to succeeding in Medical’s mission. Download your free copy of the white paper here >>>EYEFORPHARMA
eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditionsTerms and conditions DOWNLOAD YOUR EXCLUSIVE 24 PAGE WHITEPAPER BELOW GSK’s move to a new model of customer engagement has generated a great deal of debate. Indeed, many commentators remain skeptical that this ‘ethical’ model – especially the decoupling of sales incentives from prescription volume isn’t robust enough to deliver results in the long-term. DOWNLOAD THE BROCHURE NOW James Mackintosh Global Project Director jmackintosh@eyeforpharma.com +44 (0)207 375 7163 : Ben Parkes Head of Product bparkes@eyeforpharma.com ENTER YOUR DETAILS HERE TO DOWNLOAD eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditions BE THE FIRST TO READ THE FULL WHITEPAPER eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions PRE-ORDER THE BROCHURE NOW Without evidence, there can be no access – that’s why 150 of America’s most forward-thinking pharma execs in the managed markets, pricing, HEOR, analytics and data space are attending RWE & MarketAccess USA 2016.
SEE THE AGENDA AND THE SPEAKER LINE-UP, DOWNLOAD THE eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions GET YOUR FREE COPY TODAY Goodbye, Sales and Marketing. Hello, integrated Commercial team! This in-depth eyeforpharma whitepaper will explore how pharma is integrating customer-facing teams in order to become morecustomer-centric.
EVERYTHING YOU NEED TO KNOW ABOUT THE CHANGING MEDICAL The expert panel of contributors includes: Dr Ameet Nathwani, Chief Medical Officer, Sanofi Antonio Tataranni, SVP and Head of Medical Affairs, Sanofi Danie Du Plessis, Head of Medical Affairs, GlaxoSmithKline Gundula Schneidewind, VP, Medical Affairs, Takeda Michael Zaiac, Head of Medical Affairs, Celgene Mark Rees Saunders, MSL Excellence Lead, AstraZeneca DOWNLOAD YOUR FREE COPY OF THE WHITE PAPER HERE! Medical Affairs is undergoing a revolution. A new Medical model is therefore top priority across pharma’s leadership. With the help of Allergan, Takeda, Roche, Eisai, Ipsen and many more our latest white paper explores the newest approaches to succeeding in Medical’s mission. Download your free copy of the white paper here >>>EYEFORPHARMA
eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditionsTerms and conditions DOWNLOAD YOUR EXCLUSIVE 24 PAGE WHITEPAPER BELOW GSK’s move to a new model of customer engagement has generated a great deal of debate. Indeed, many commentators remain skeptical that this ‘ethical’ model – especially the decoupling of sales incentives from prescription volume isn’t robust enough to deliver results in the long-term. DOWNLOAD THE BROCHURE NOW James Mackintosh Global Project Director jmackintosh@eyeforpharma.com +44 (0)207 375 7163 : Ben Parkes Head of Product bparkes@eyeforpharma.com ENTER YOUR DETAILS HERE TO DOWNLOAD eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditions BE THE FIRST TO READ THE FULL WHITEPAPER eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions PRE-ORDER THE BROCHURE NOW Without evidence, there can be no access – that’s why 150 of America’s most forward-thinking pharma execs in the managed markets, pricing, HEOR, analytics and data space are attending RWE & MarketAccess USA 2016.
EYEFORPHARMA
eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditionsTerms and conditions GET THE BRIEFING NOW eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions GET YOUR FREE COPY TODAY Download eyeforpharma’s latest industry whitepaper featuring key contributions from Astellas, Takeda and AstraZeneca including:. Exclusive results from the “DTC Attitudes, Behaviours and Preferences” study- what do patients think about DTC? How listening to patient needs and involving them in the design of advertising is winning champions and delivering results DOWNLOAD YOUR FREE COPY OF THE WHITE PAPER HERE! Medical Affairs is undergoing a revolution. A new Medical model is therefore top priority across pharma’s leadership. With the help of Allergan, Takeda, Roche, Eisai, Ipsen and many more our latest white paper explores the newest approaches to succeeding in Medical’s mission. Download your free copy of the white paper here >>> DOWNLOAD YOUR BROCHURE NOW eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditions DOWNLOAD THE BROCHURE NOW James Mackintosh Global Project Director jmackintosh@eyeforpharma.com +44 (0)207 375 7163 : Ben Parkes Head of Product bparkes@eyeforpharma.com DOWNLOAD THE BROCHURE NOW: “Loyalty is incredibly profitable,” says customer experience specialist and former Customer Experience Lead for Pfizer Europe, Mike Bellis. “Creating loyalty means you don’t have to work so hard to sell, improving your operational efficiency and profit margins. ENTER YOUR DETAILS HERE TO DOWNLOAD eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditions DOWNLOAD YOUR BROCHURE eyeforpharma Barcelona is the only place to be for 2016. The global event brings together leading pharma executives to share how you can address the era of customer and patient empowerment. PRE-ORDER THE BROCHURE NOW Without evidence, there can be no access – that’s why 150 of America’s most forward-thinking pharma execs in the managed markets, pricing, HEOR, analytics and data space are attending RWE & MarketAccess USA 2016.
SEE THE AGENDA AND THE SPEAKER LINE-UP, DOWNLOAD THE eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions GET YOUR FREE COPY TODAY Goodbye, Sales and Marketing. Hello, integrated Commercial team! This in-depth eyeforpharma whitepaper will explore how pharma is integrating customer-facing teams in order to become morecustomer-centric.
EVERYTHING YOU NEED TO KNOW ABOUT THE CHANGING MEDICAL The expert panel of contributors includes: Dr Ameet Nathwani, Chief Medical Officer, Sanofi Antonio Tataranni, SVP and Head of Medical Affairs, Sanofi Danie Du Plessis, Head of Medical Affairs, GlaxoSmithKline Gundula Schneidewind, VP, Medical Affairs, Takeda Michael Zaiac, Head of Medical Affairs, Celgene Mark Rees Saunders, MSL Excellence Lead, AstraZeneca DOWNLOAD YOUR FREE COPY OF THE WHITE PAPER HERE! Medical Affairs is undergoing a revolution. A new Medical model is therefore top priority across pharma’s leadership. With the help of Allergan, Takeda, Roche, Eisai, Ipsen and many more our latest white paper explores the newest approaches to succeeding in Medical’s mission. Download your free copy of the white paper here >>>EYEFORPHARMA
eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditionsTerms and conditions DOWNLOAD YOUR EXCLUSIVE 24 PAGE WHITEPAPER BELOW GSK’s move to a new model of customer engagement has generated a great deal of debate. Indeed, many commentators remain skeptical that this ‘ethical’ model – especially the decoupling of sales incentives from prescription volume isn’t robust enough to deliver results in the long-term. ENTER YOUR DETAILS HERE TO DOWNLOAD eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditionsWHITEPAPER DOWNLOAD
Beyond a few organisations where entire teams and roles have been created around the pursuit of true ‘patient centricity’, some of pharma’s most important customer-facing functions are unclear on the necessary steps needed to be worthy of the title ‘patient-centric’ – and even whether or not it should be their objective at all. BE THE FIRST TO READ THE FULL WHITEPAPER eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions PRE-ORDER THE BROCHURE NOW Without evidence, there can be no access – that’s why 150 of America’s most forward-thinking pharma execs in the managed markets, pricing, HEOR, analytics and data space are attending RWE & MarketAccess USA 2016.
SEE THE AGENDA AND THE SPEAKER LINE-UP, DOWNLOAD THE eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions GET YOUR FREE COPY TODAY Goodbye, Sales and Marketing. Hello, integrated Commercial team! This in-depth eyeforpharma whitepaper will explore how pharma is integrating customer-facing teams in order to become morecustomer-centric.
EVERYTHING YOU NEED TO KNOW ABOUT THE CHANGING MEDICAL The expert panel of contributors includes: Dr Ameet Nathwani, Chief Medical Officer, Sanofi Antonio Tataranni, SVP and Head of Medical Affairs, Sanofi Danie Du Plessis, Head of Medical Affairs, GlaxoSmithKline Gundula Schneidewind, VP, Medical Affairs, Takeda Michael Zaiac, Head of Medical Affairs, Celgene Mark Rees Saunders, MSL Excellence Lead, AstraZeneca DOWNLOAD YOUR FREE COPY OF THE WHITE PAPER HERE! Medical Affairs is undergoing a revolution. A new Medical model is therefore top priority across pharma’s leadership. With the help of Allergan, Takeda, Roche, Eisai, Ipsen and many more our latest white paper explores the newest approaches to succeeding in Medical’s mission. Download your free copy of the white paper here >>>EYEFORPHARMA
eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditionsTerms and conditions DOWNLOAD YOUR EXCLUSIVE 24 PAGE WHITEPAPER BELOW GSK’s move to a new model of customer engagement has generated a great deal of debate. Indeed, many commentators remain skeptical that this ‘ethical’ model – especially the decoupling of sales incentives from prescription volume isn’t robust enough to deliver results in the long-term. ENTER YOUR DETAILS HERE TO DOWNLOAD eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditionsWHITEPAPER DOWNLOAD
Beyond a few organisations where entire teams and roles have been created around the pursuit of true ‘patient centricity’, some of pharma’s most important customer-facing functions are unclear on the necessary steps needed to be worthy of the title ‘patient-centric’ – and even whether or not it should be their objective at all. BE THE FIRST TO READ THE FULL WHITEPAPER eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions PRE-ORDER THE BROCHURE NOW Without evidence, there can be no access – that’s why 150 of America’s most forward-thinking pharma execs in the managed markets, pricing, HEOR, analytics and data space are attending RWE & MarketAccess USA 2016.
EYEFORPHARMA
eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditionsTerms and conditions GET THE BRIEFING NOW eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions GET YOUR FREE COPY TODAY Download eyeforpharma’s latest industry whitepaper featuring key contributions from Astellas, Takeda and AstraZeneca including:. Exclusive results from the “DTC Attitudes, Behaviours and Preferences” study- what do patients think about DTC? How listening to patient needs and involving them in the design of advertising is winning champions and delivering results DOWNLOAD YOUR FREE COPY OF THE WHITE PAPER HERE! Medical Affairs is undergoing a revolution. A new Medical model is therefore top priority across pharma’s leadership. With the help of Allergan, Takeda, Roche, Eisai, Ipsen and many more our latest white paper explores the newest approaches to succeeding in Medical’s mission. Download your free copy of the white paper here >>> DOWNLOAD YOUR BROCHURE NOW eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditions DOWNLOAD THE BROCHURE NOW James Mackintosh Global Project Director jmackintosh@eyeforpharma.com +44 (0)207 375 7163 : Ben Parkes Head of Product bparkes@eyeforpharma.com DOWNLOAD THE BROCHURE NOW: “Loyalty is incredibly profitable,” says customer experience specialist and former Customer Experience Lead for Pfizer Europe, Mike Bellis. “Creating loyalty means you don’t have to work so hard to sell, improving your operational efficiency and profit margins. ENTER YOUR DETAILS HERE TO DOWNLOAD eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditions DOWNLOAD YOUR BROCHURE eyeforpharma Barcelona is the only place to be for 2016. The global event brings together leading pharma executives to share how you can address the era of customer and patient empowerment. PRE-ORDER THE BROCHURE NOW Without evidence, there can be no access – that’s why 150 of America’s most forward-thinking pharma execs in the managed markets, pricing, HEOR, analytics and data space are attending RWE & MarketAccess USA 2016.
SEE THE AGENDA AND THE SPEAKER LINE-UP, DOWNLOAD THE eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions GET YOUR FREE COPY TODAY Goodbye, Sales and Marketing. Hello, integrated Commercial team! This in-depth eyeforpharma whitepaper will explore how pharma is integrating customer-facing teams in order to become morecustomer-centric.
EVERYTHING YOU NEED TO KNOW ABOUT THE CHANGING MEDICAL The expert panel of contributors includes: Dr Ameet Nathwani, Chief Medical Officer, Sanofi Antonio Tataranni, SVP and Head of Medical Affairs, Sanofi Danie Du Plessis, Head of Medical Affairs, GlaxoSmithKline Gundula Schneidewind, VP, Medical Affairs, Takeda Michael Zaiac, Head of Medical Affairs, Celgene Mark Rees Saunders, MSL Excellence Lead, AstraZeneca DOWNLOAD YOUR FREE COPY OF THE WHITE PAPER HERE! Medical Affairs is undergoing a revolution. A new Medical model is therefore top priority across pharma’s leadership. With the help of Allergan, Takeda, Roche, Eisai, Ipsen and many more our latest white paper explores the newest approaches to succeeding in Medical’s mission. Download your free copy of the white paper here >>>EYEFORPHARMA
eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditionsTerms and conditions DOWNLOAD YOUR EXCLUSIVE 24 PAGE WHITEPAPER BELOW GSK’s move to a new model of customer engagement has generated a great deal of debate. Indeed, many commentators remain skeptical that this ‘ethical’ model – especially the decoupling of sales incentives from prescription volume isn’t robust enough to deliver results in the long-term. ENTER YOUR DETAILS HERE TO DOWNLOAD eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditionsWHITEPAPER DOWNLOAD
Beyond a few organisations where entire teams and roles have been created around the pursuit of true ‘patient centricity’, some of pharma’s most important customer-facing functions are unclear on the necessary steps needed to be worthy of the title ‘patient-centric’ – and even whether or not it should be their objective at all. BE THE FIRST TO READ THE FULL WHITEPAPER eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions PRE-ORDER THE BROCHURE NOW Without evidence, there can be no access – that’s why 150 of America’s most forward-thinking pharma execs in the managed markets, pricing, HEOR, analytics and data space are attending RWE & MarketAccess USA 2016.
SEE THE AGENDA AND THE SPEAKER LINE-UP, DOWNLOAD THE eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions GET YOUR FREE COPY TODAY Goodbye, Sales and Marketing. Hello, integrated Commercial team! This in-depth eyeforpharma whitepaper will explore how pharma is integrating customer-facing teams in order to become morecustomer-centric.
EVERYTHING YOU NEED TO KNOW ABOUT THE CHANGING MEDICAL The expert panel of contributors includes: Dr Ameet Nathwani, Chief Medical Officer, Sanofi Antonio Tataranni, SVP and Head of Medical Affairs, Sanofi Danie Du Plessis, Head of Medical Affairs, GlaxoSmithKline Gundula Schneidewind, VP, Medical Affairs, Takeda Michael Zaiac, Head of Medical Affairs, Celgene Mark Rees Saunders, MSL Excellence Lead, AstraZeneca DOWNLOAD YOUR FREE COPY OF THE WHITE PAPER HERE! Medical Affairs is undergoing a revolution. A new Medical model is therefore top priority across pharma’s leadership. With the help of Allergan, Takeda, Roche, Eisai, Ipsen and many more our latest white paper explores the newest approaches to succeeding in Medical’s mission. Download your free copy of the white paper here >>>EYEFORPHARMA
eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditionsTerms and conditions DOWNLOAD YOUR EXCLUSIVE 24 PAGE WHITEPAPER BELOW GSK’s move to a new model of customer engagement has generated a great deal of debate. Indeed, many commentators remain skeptical that this ‘ethical’ model – especially the decoupling of sales incentives from prescription volume isn’t robust enough to deliver results in the long-term. ENTER YOUR DETAILS HERE TO DOWNLOAD eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditionsWHITEPAPER DOWNLOAD
Beyond a few organisations where entire teams and roles have been created around the pursuit of true ‘patient centricity’, some of pharma’s most important customer-facing functions are unclear on the necessary steps needed to be worthy of the title ‘patient-centric’ – and even whether or not it should be their objective at all. BE THE FIRST TO READ THE FULL WHITEPAPER eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions PRE-ORDER THE BROCHURE NOW Without evidence, there can be no access – that’s why 150 of America’s most forward-thinking pharma execs in the managed markets, pricing, HEOR, analytics and data space are attending RWE & MarketAccess USA 2016.
EYEFORPHARMA
eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditionsTerms and conditions GET THE BRIEFING NOW eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions GET YOUR FREE COPY TODAY Download eyeforpharma’s latest industry whitepaper featuring key contributions from Astellas, Takeda and AstraZeneca including:. Exclusive results from the “DTC Attitudes, Behaviours and Preferences” study- what do patients think about DTC? How listening to patient needs and involving them in the design of advertising is winning champions and delivering results DOWNLOAD YOUR FREE COPY OF THE WHITE PAPER HERE! Medical Affairs is undergoing a revolution. A new Medical model is therefore top priority across pharma’s leadership. With the help of Allergan, Takeda, Roche, Eisai, Ipsen and many more our latest white paper explores the newest approaches to succeeding in Medical’s mission. Download your free copy of the white paper here >>> DOWNLOAD YOUR BROCHURE NOW eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditions DOWNLOAD THE BROCHURE NOW James Mackintosh Global Project Director jmackintosh@eyeforpharma.com +44 (0)207 375 7163 : Ben Parkes Head of Product bparkes@eyeforpharma.com DOWNLOAD THE BROCHURE NOW: “Loyalty is incredibly profitable,” says customer experience specialist and former Customer Experience Lead for Pfizer Europe, Mike Bellis. “Creating loyalty means you don’t have to work so hard to sell, improving your operational efficiency and profit margins. ENTER YOUR DETAILS HERE TO DOWNLOAD eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditions DOWNLOAD YOUR BROCHURE eyeforpharma Barcelona is the only place to be for 2016. The global event brings together leading pharma executives to share how you can address the era of customer and patient empowerment. PRE-ORDER THE BROCHURE NOW Without evidence, there can be no access – that’s why 150 of America’s most forward-thinking pharma execs in the managed markets, pricing, HEOR, analytics and data space are attending RWE & MarketAccess USA 2016.
SEE THE AGENDA AND THE SPEAKER LINE-UP, DOWNLOAD THE eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions GET YOUR FREE COPY TODAY Goodbye, Sales and Marketing. Hello, integrated Commercial team! This in-depth eyeforpharma whitepaper will explore how pharma is integrating customer-facing teams in order to become morecustomer-centric.
EVERYTHING YOU NEED TO KNOW ABOUT THE CHANGING MEDICAL The expert panel of contributors includes: Dr Ameet Nathwani, Chief Medical Officer, Sanofi Antonio Tataranni, SVP and Head of Medical Affairs, Sanofi Danie Du Plessis, Head of Medical Affairs, GlaxoSmithKline Gundula Schneidewind, VP, Medical Affairs, Takeda Michael Zaiac, Head of Medical Affairs, Celgene Mark Rees Saunders, MSL Excellence Lead, AstraZeneca DOWNLOAD YOUR FREE COPY OF THE WHITE PAPER HERE! Medical Affairs is undergoing a revolution. A new Medical model is therefore top priority across pharma’s leadership. With the help of Allergan, Takeda, Roche, Eisai, Ipsen and many more our latest white paper explores the newest approaches to succeeding in Medical’s mission. Download your free copy of the white paper here >>>EYEFORPHARMA
eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditionsTerms and conditions DOWNLOAD YOUR EXCLUSIVE 24 PAGE WHITEPAPER BELOW GSK’s move to a new model of customer engagement has generated a great deal of debate. Indeed, many commentators remain skeptical that this ‘ethical’ model – especially the decoupling of sales incentives from prescription volume isn’t robust enough to deliver results in the long-term. BE THE FIRST TO READ THE FULL WHITEPAPER eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditionsWHITEPAPER DOWNLOAD
Beyond a few organisations where entire teams and roles have been created around the pursuit of true ‘patient centricity’, some of pharma’s most important customer-facing functions are unclear on the necessary steps needed to be worthy of the title ‘patient-centric’ – and even whether or not it should be their objective at all. PRE-ORDER THE BROCHURE NOW Without evidence, there can be no access – that’s why 150 of America’s most forward-thinking pharma execs in the managed markets, pricing, HEOR, analytics and data space are attending RWE & MarketAccess USA 2016.
DOWNLOAD YOUR COPY OF THE PATIENT SUMMIT If you have trouble viewing the pdf please click here. This magazine was published as part of the run up to Patient Summit Europe. Our expert speaker line-up will share the good, the bad and the groundbreaking key lessons learnt from their years of collectiveexperience.
SEE THE AGENDA AND THE SPEAKER LINE-UP, DOWNLOAD THE eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions GET YOUR FREE COPY TODAY Goodbye, Sales and Marketing. Hello, integrated Commercial team! This in-depth eyeforpharma whitepaper will explore how pharma is integrating customer-facing teams in order to become morecustomer-centric.
EVERYTHING YOU NEED TO KNOW ABOUT THE CHANGING MEDICAL The expert panel of contributors includes: Dr Ameet Nathwani, Chief Medical Officer, Sanofi Antonio Tataranni, SVP and Head of Medical Affairs, Sanofi Danie Du Plessis, Head of Medical Affairs, GlaxoSmithKline Gundula Schneidewind, VP, Medical Affairs, Takeda Michael Zaiac, Head of Medical Affairs, Celgene Mark Rees Saunders, MSL Excellence Lead, AstraZeneca DOWNLOAD YOUR FREE COPY OF THE WHITE PAPER HERE! Medical Affairs is undergoing a revolution. A new Medical model is therefore top priority across pharma’s leadership. With the help of Allergan, Takeda, Roche, Eisai, Ipsen and many more our latest white paper explores the newest approaches to succeeding in Medical’s mission. Download your free copy of the white paper here >>>EYEFORPHARMA
eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditionsTerms and conditions DOWNLOAD YOUR EXCLUSIVE 24 PAGE WHITEPAPER BELOW GSK’s move to a new model of customer engagement has generated a great deal of debate. Indeed, many commentators remain skeptical that this ‘ethical’ model – especially the decoupling of sales incentives from prescription volume isn’t robust enough to deliver results in the long-term. BE THE FIRST TO READ THE FULL WHITEPAPER eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditionsWHITEPAPER DOWNLOAD
Beyond a few organisations where entire teams and roles have been created around the pursuit of true ‘patient centricity’, some of pharma’s most important customer-facing functions are unclear on the necessary steps needed to be worthy of the title ‘patient-centric’ – and even whether or not it should be their objective at all. PRE-ORDER THE BROCHURE NOW Without evidence, there can be no access – that’s why 150 of America’s most forward-thinking pharma execs in the managed markets, pricing, HEOR, analytics and data space are attending RWE & MarketAccess USA 2016.
DOWNLOAD YOUR COPY OF THE PATIENT SUMMIT If you have trouble viewing the pdf please click here. This magazine was published as part of the run up to Patient Summit Europe. Our expert speaker line-up will share the good, the bad and the groundbreaking key lessons learnt from their years of collectiveexperience.
EYEFORPHARMA
eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditionsTerms and conditions GET THE BRIEFING NOW eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions GET YOUR FREE COPY TODAY Download eyeforpharma’s latest industry whitepaper featuring key contributions from Astellas, Takeda and AstraZeneca including:. Exclusive results from the “DTC Attitudes, Behaviours and Preferences” study- what do patients think about DTC? How listening to patient needs and involving them in the design of advertising is winning champions and delivering results DOWNLOAD YOUR FREE COPY OF THE WHITE PAPER HERE! Medical Affairs is undergoing a revolution. A new Medical model is therefore top priority across pharma’s leadership. With the help of Allergan, Takeda, Roche, Eisai, Ipsen and many more our latest white paper explores the newest approaches to succeeding in Medical’s mission. Download your free copy of the white paper here >>> BE THE FIRST TO READ THE FULL WHITEPAPER eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions DOWNLOAD THE BROCHURE NOW: “Loyalty is incredibly profitable,” says customer experience specialist and former Customer Experience Lead for Pfizer Europe, Mike Bellis. “Creating loyalty means you don’t have to work so hard to sell, improving your operational efficiency and profit margins. DOWNLOAD THE BROCHURE NOW James Mackintosh Global Project Director jmackintosh@eyeforpharma.com +44 (0)207 375 7163 : Ben Parkes Head of Product bparkes@eyeforpharma.com DOWNLOAD YOUR BROCHURE eyeforpharma Barcelona is the only place to be for 2016. The global event brings together leading pharma executives to share how you can address the era of customer and patient empowerment. DOWNLOAD THE BROCHURE NOW: At eyeforpharma Philadelphia 2018 we encourage the most inspiring and forward-thinking leaders from our industry to share their ideas, lessons learnt and case studies on how they have turned insights from patients and customers into genuine healthcare innovations. PRE-ORDER THE BROCHURE NOW Without evidence, there can be no access – that’s why 150 of America’s most forward-thinking pharma execs in the managed markets, pricing, HEOR, analytics and data space are attending RWE & MarketAccess USA 2016.
SEE THE AGENDA AND THE SPEAKER LINE-UP, DOWNLOAD THE eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions DOWNLOAD YOUR FREE COPY OF THE WHITE PAPER HERE! Medical Affairs is undergoing a revolution. A new Medical model is therefore top priority across pharma’s leadership. With the help of Allergan, Takeda, Roche, Eisai, Ipsen and many more our latest white paper explores the newest approaches to succeeding in Medical’s mission. Download your free copy of the white paper here >>> EVERYTHING YOU NEED TO KNOW ABOUT THE CHANGING MEDICAL The expert panel of contributors includes: Dr Ameet Nathwani, Chief Medical Officer, Sanofi Antonio Tataranni, SVP and Head of Medical Affairs, Sanofi Danie Du Plessis, Head of Medical Affairs, GlaxoSmithKline Gundula Schneidewind, VP, Medical Affairs, Takeda Michael Zaiac, Head of Medical Affairs, Celgene Mark Rees Saunders, MSL Excellence Lead, AstraZeneca GET THE BRIEFING NOW eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions DOWNLOAD YOUR EXCLUSIVE 24 PAGE WHITEPAPER BELOW GSK’s move to a new model of customer engagement has generated a great deal of debate. Indeed, many commentators remain skeptical that this ‘ethical’ model – especially the decoupling of sales incentives from prescription volume isn’t robust enough to deliver results in the long-term. DOWNLOAD THE BROCHURE NOW: At eyeforpharma Philadelphia 2018 we encourage the most inspiring and forward-thinking leaders from our industry to share their ideas, lessons learnt and case studies on how they have turned insights from patients and customers into genuine healthcare innovations. SEE THE AGENDA AND THE SPEAKER LINE-UP, DOWNLOAD THE eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions DOWNLOAD YOUR FREE COPY OF THE WHITE PAPER HERE! Medical Affairs is undergoing a revolution. A new Medical model is therefore top priority across pharma’s leadership. With the help of Allergan, Takeda, Roche, Eisai, Ipsen and many more our latest white paper explores the newest approaches to succeeding in Medical’s mission. Download your free copy of the white paper here >>> EVERYTHING YOU NEED TO KNOW ABOUT THE CHANGING MEDICAL The expert panel of contributors includes: Dr Ameet Nathwani, Chief Medical Officer, Sanofi Antonio Tataranni, SVP and Head of Medical Affairs, Sanofi Danie Du Plessis, Head of Medical Affairs, GlaxoSmithKline Gundula Schneidewind, VP, Medical Affairs, Takeda Michael Zaiac, Head of Medical Affairs, Celgene Mark Rees Saunders, MSL Excellence Lead, AstraZeneca GET THE BRIEFING NOW eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions DOWNLOAD YOUR EXCLUSIVE 24 PAGE WHITEPAPER BELOW GSK’s move to a new model of customer engagement has generated a great deal of debate. Indeed, many commentators remain skeptical that this ‘ethical’ model – especially the decoupling of sales incentives from prescription volume isn’t robust enough to deliver results in the long-term. DOWNLOAD THE BROCHURE NOW: At eyeforpharma Philadelphia 2018 we encourage the most inspiring and forward-thinking leaders from our industry to share their ideas, lessons learnt and case studies on how they have turned insights from patients and customers into genuine healthcare innovations. GET YOUR FREE COPY TODAY Goodbye, Sales and Marketing. Hello, integrated Commercial team! This in-depth eyeforpharma whitepaper will explore how pharma is integrating customer-facing teams in order to become morecustomer-centric.
DOWNLOAD YOUR FREE COPY OF THE WHITE PAPER HERE! Medical Affairs is undergoing a revolution. A new Medical model is therefore top priority across pharma’s leadership. With the help of Allergan, Takeda, Roche, Eisai, Ipsen and many more our latest white paper explores the newest approaches to succeeding in Medical’s mission. Download your free copy of the white paper here >>>REUTERS EVENTS
eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions DOWNLOAD YOUR EXCLUSIVE 24 PAGE WHITEPAPER BELOW GSK’s move to a new model of customer engagement has generated a great deal of debate. Indeed, many commentators remain skeptical that this ‘ethical’ model – especially the decoupling of sales incentives from prescription volume isn’t robust enough to deliver results in the long-term. DOWNLOAD THE BROCHURE NOW: At eyeforpharma Philadelphia 2018 we encourage the most inspiring and forward-thinking leaders from our industry to share their ideas, lessons learnt and case studies on how they have turned insights from patients and customers into genuine healthcare innovations. DOWNLOAD YOUR BROCHURE eyeforpharma Barcelona is the only place to be for 2016. The global event brings together leading pharma executives to share how you can address the era of customer and patient empowerment. SEE THE AGENDA AND THE SPEAKER LINE-UP, DOWNLOAD THE eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions DOWNLOAD YOUR FREE COPY OF THE WHITE PAPER HERE! Medical Affairs is undergoing a revolution. A new Medical model is therefore top priority across pharma’s leadership. With the help of Allergan, Takeda, Roche, Eisai, Ipsen and many more our latest white paper explores the newest approaches to succeeding in Medical’s mission. Download your free copy of the white paper here >>> EVERYTHING YOU NEED TO KNOW ABOUT THE CHANGING MEDICAL The expert panel of contributors includes: Dr Ameet Nathwani, Chief Medical Officer, Sanofi Antonio Tataranni, SVP and Head of Medical Affairs, Sanofi Danie Du Plessis, Head of Medical Affairs, GlaxoSmithKline Gundula Schneidewind, VP, Medical Affairs, Takeda Michael Zaiac, Head of Medical Affairs, Celgene Mark Rees Saunders, MSL Excellence Lead, AstraZeneca GET THE BRIEFING NOW eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions DOWNLOAD YOUR EXCLUSIVE 24 PAGE WHITEPAPER BELOW GSK’s move to a new model of customer engagement has generated a great deal of debate. Indeed, many commentators remain skeptical that this ‘ethical’ model – especially the decoupling of sales incentives from prescription volume isn’t robust enough to deliver results in the long-term. DOWNLOAD THE BROCHURE NOW: At eyeforpharma Philadelphia 2018 we encourage the most inspiring and forward-thinking leaders from our industry to share their ideas, lessons learnt and case studies on how they have turned insights from patients and customers into genuine healthcare innovations. SEE THE AGENDA AND THE SPEAKER LINE-UP, DOWNLOAD THE eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions DOWNLOAD YOUR FREE COPY OF THE WHITE PAPER HERE! Medical Affairs is undergoing a revolution. A new Medical model is therefore top priority across pharma’s leadership. With the help of Allergan, Takeda, Roche, Eisai, Ipsen and many more our latest white paper explores the newest approaches to succeeding in Medical’s mission. Download your free copy of the white paper here >>> EVERYTHING YOU NEED TO KNOW ABOUT THE CHANGING MEDICAL The expert panel of contributors includes: Dr Ameet Nathwani, Chief Medical Officer, Sanofi Antonio Tataranni, SVP and Head of Medical Affairs, Sanofi Danie Du Plessis, Head of Medical Affairs, GlaxoSmithKline Gundula Schneidewind, VP, Medical Affairs, Takeda Michael Zaiac, Head of Medical Affairs, Celgene Mark Rees Saunders, MSL Excellence Lead, AstraZeneca GET THE BRIEFING NOW eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions DOWNLOAD YOUR EXCLUSIVE 24 PAGE WHITEPAPER BELOW GSK’s move to a new model of customer engagement has generated a great deal of debate. Indeed, many commentators remain skeptical that this ‘ethical’ model – especially the decoupling of sales incentives from prescription volume isn’t robust enough to deliver results in the long-term. DOWNLOAD THE BROCHURE NOW: At eyeforpharma Philadelphia 2018 we encourage the most inspiring and forward-thinking leaders from our industry to share their ideas, lessons learnt and case studies on how they have turned insights from patients and customers into genuine healthcare innovations. GET YOUR FREE COPY TODAY Goodbye, Sales and Marketing. Hello, integrated Commercial team! This in-depth eyeforpharma whitepaper will explore how pharma is integrating customer-facing teams in order to become morecustomer-centric.
DOWNLOAD YOUR FREE COPY OF THE WHITE PAPER HERE! Medical Affairs is undergoing a revolution. A new Medical model is therefore top priority across pharma’s leadership. With the help of Allergan, Takeda, Roche, Eisai, Ipsen and many more our latest white paper explores the newest approaches to succeeding in Medical’s mission. Download your free copy of the white paper here >>>REUTERS EVENTS
eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions DOWNLOAD YOUR EXCLUSIVE 24 PAGE WHITEPAPER BELOW GSK’s move to a new model of customer engagement has generated a great deal of debate. Indeed, many commentators remain skeptical that this ‘ethical’ model – especially the decoupling of sales incentives from prescription volume isn’t robust enough to deliver results in the long-term. DOWNLOAD THE BROCHURE NOW: At eyeforpharma Philadelphia 2018 we encourage the most inspiring and forward-thinking leaders from our industry to share their ideas, lessons learnt and case studies on how they have turned insights from patients and customers into genuine healthcare innovations. DOWNLOAD YOUR BROCHURE eyeforpharma Barcelona is the only place to be for 2016. The global event brings together leading pharma executives to share how you can address the era of customer and patient empowerment.LOGIN
Username or e-mail *Password *
* Forgotten Password?Subscribe
| Forgot your password? Close log in window __* Newsletter |
* Log In
Reuters Events | Pharma Thought leadership and innovation for the Pharmaceutical IndustrySearch this site
* Home
* Topics
* Commercial
* Access and Evidence* Clinical
* Patients and Medical* Research
* Reports
* White Papers and reports * Conference Slides, Videos, Audio* Webinars
* Events
* About/contact
* Contact Us
* Management Team
* Sponsor content
Menu __
Fixing the broken patient search experience There’s opportunity as well as danger in the billion healthcare searches made every day. Why isn’t pharma tuning in?Medical
ON THE JOURNEY FROM PILL TO PLATFORM As pharma’s business model increasingly moves beyond the pill towards the patient and the entire therapeutic context, Medical...Medical
FROM INSIGHT TO ACTION IN MEDICAL AFFAIRS The context of most human engagement has been limited to the digital space thanks to the current pandemic. Around two thirds...LATEST
*
Patients and Medical OPTIMIZING PATIENT ENGAGEMENT IN TRIALS Joseph Constance , (May 23, 2021) The importance of involving the patient at all stages of trials post-pandemic has never been clearer*
Patients and Medical FIXING THE BROKEN PATIENT SEARCH EXPERIENCE Andrew Stone , (May 23, 2021) There’s opportunity as well as danger in the billion healthcare searches made every day. Why isn’t pharma tuning in?*
Access and Evidence
INCLUDING THE CAREGIVER IN ACCESS SUBMISSIONS Katie Osborne , (May 23, 2021) Partnering with caregivers can help build a more powerful case for re-imbursement if pharma can gather the right evidence*
Medical
FROM INSIGHT TO ACTION IN MEDICAL AFFAIRS Nicola Davies , (May 6, 2021) Physicians’ increasingly digital-first consumption of disease state education offers pharma a way to understand their needs more deeply and so find better ways to serve them*
Clinical
HOW COLLABORATION WILL STRENGTHEN THE FUTURE OF CELL AND GENETHERAPIES
Adlai Goldberg , (Apr 6, 2021) As clinical science continues to deliver on the promise of CGT, how can the industry make them available and affordable at scale?More Content
MOST POPULAR
Fixing the broken patient search experience Andrew Stone , (May 23, 2021) There’s opportunity as well as danger in the billion healthcare searches made every day. Why isn’t pharma tuning in? From insight to action in medical affairs Nicola Davies , (May 6, 2021) Physicians’ increasingly digital-first consumption of disease state education offers pharma a way to understand their needs more deeply and so find better ways to serve them How US pharma is charting a new course in a changed world Tom Disley , (Apr 6, 2021) Post-Trump and post pandemic, pharma in the US is eyeing emerging commercial and clinical opportunities, but must reckon with potentialstorms ahead
OPINION
Up close and personal: Reacting in a crisis - The Naji Gehchan story Jill Donahue , (Mar 11, 2021) This pharma leader worked in a war zone. Now he’s using the same tactics to navigate the pandemic Up close and personal: A life of service - The Dr. Dirk VanderMijnsbrugge story
Jill Donahue , (Oct 2, 2020) Pfizer's Medical Affairs Lead, Rare Diseases, talks about purpose, patients and pharma's power to do goodMore Columns
COMMERCIAL
*
ACCELERATING COMMERCIAL SUCCESS IN CAGT Dean Griffiths , (Mar 22, 2021) To build on the successes thus far in cell and gene therapy, pharma must foster further payer, physician and patient buy-in*
BLENDED AND AUGMENTED: REIMAGINING THE ROLE OF THE REP Andrew Stone , (Dec 18, 2020) The events of 2020 have compelled pharma to reimagine the role of the rep to better adapt to the new rules of engagement*
UNCORKING THE COMPLIANCE BOTTLENECKS IN DIGITAL Andrew Stone , (Dec 17, 2020) The sudden demand for digital content this year has created serious compliance bottlenecks that pharma is racing to overcome with new processes and technology*
CREATING A HOLISTIC CUSTOMER EXPERIENCE Rhonda Siddall , (Nov 17, 2020) Finding solutions to unmet customer needs means harnessing the combined power of medical and marketing skills – and creating aculture to match
*
ADAPTING TO THE MULTICHANNEL IMPERATIVE: A SPECIAL REPORT Andrew Stone , (Oct 8, 2020) Pharma’s gradual evolution into digital-first commercial has become urgent in the COVID-19 world. A comprehensive multi-channel approach including the use of digital tools to enhance customer engagement will transform pharma sales.More Commercial
ACCESS AND EVIDENCE
*
INCLUDING THE CAREGIVER IN ACCESS SUBMISSIONS Katie Osborne , (May 23, 2021) Partnering with caregivers can help build a more powerful case for re-imbursement if pharma can gather the right evidence*
A BURNING DESIRE TO MAKE A DIFFERENCE FOR PATIENTS Andrew Stone , (Apr 19, 2020) Annexus Health, eyeforpharma’s 2020 Health Start-up winner is on a mission for patients*
FROM REACTIVE TO PREDICTIVE: CONCERTO’S NEW COMPOSITIONS Andrew Stone , (Apr 10, 2020) Artificial Intelligence has only just begun to unlock high value innovation. The latest predictive tools will break new ground, says Concerto HealthAI’s Jeff Elton*
EVOLVING HTA FRAMEWORKS TO ACCELERATE INNOVATION Andrew Stone , (Mar 14, 2020) Iterative evidence generation and demonstrating value over time could help unlock delays in getting cures out, saving more lives, says Janssen’s Clare Hague*
CAN WE AFFORD TO PAY FOR FUTURE CURES? Ulrich Neumann , (Jan 24, 2020) Medical innovation is racing ahead of healthcare’s ability to innovate on payments, but new ideas are emergingMore Market Access
PATIENTS AND MEDICAL*
OPTIMIZING PATIENT ENGAGEMENT IN TRIALS Joseph Constance , (May 23, 2021) The importance of involving the patient at all stages of trials post-pandemic has never been clearer*
FIXING THE BROKEN PATIENT SEARCH EXPERIENCE Andrew Stone , (May 23, 2021) There’s opportunity as well as danger in the billion healthcare searches made every day. Why isn’t pharma tuning in?*
THE VALUE IN MEASURING THE PATIENT EXPERIENCE Andrew Stone , (Feb 22, 2021) Pharma can improve outcomes, products and HCP relationships using technology to capture patients’ day-to-day experience of theirdisease
*
BETTER RESEARCH THROUGH PATIENT INSIGHTS Andrew Stone , (Jan 26, 2021) AstraZeneca’s innovations in chronic kidney disease are pointing the way to new ways of involving patients and RWE to drive new insightsand better outcomes
*
BUILDING A HEALTH EQUITY CULTURE Andrew Stone , (Nov 17, 2020) Health inequities, often a legacy of racism, lie heavy on the healthcare sector in the US and beyond. Fixing the problem will require long-term effort on multiple fronts More Patients and MedicalLATEST VIDEOS
__ Michel Pairet, Member of Board of Managing Directors at Boehringer Ingelheim on COVID-19 research __ Cue Biopharma: Diagnostic & disease detection to transformbiopharma
__ Dr Avi Spira: Janssen's use of new technology to intercept lungcancer
__ The Eisenbahnscheinbewegung Risk __ Act like SARS and go viral with patient centricityUPCOMING EVENTS
View All Events
JUNE 2021
*
FREE WEBINAR: A NEW ERA OF OUTSOURCING: IMPROVE EFFICIENCY AND STREAMLINE TRIAL SOLUTIONS WITH A PERSONALISED APPROACH Jun 10, 2021 - Jun 10, 2021*
FREE WEBINAR: DEVELOP A COLLABORATIVE DELIVERY NETWORK FOR CELL ANDGENE THERAPIES
Jun 15, 2021 - Jun 15, 2021*
DIGITAL HEALTH
Jun 16, 2021 - Jun 17, 2021 Digital conference, exhibition & networking*
FREE WEBINAR: PHARMA’S CLIMATE GOALS: THE ROADMAP TO DELIVERY Jun 17, 2021 - Jun 17, 2021*
FREE WEBINAR: STREAMLINE YOUR DIGITAL GO-TO-MARKET STRATEGY FORSPECIALTY PRODUCTS
Jun 24, 2021 - Jun 24, 2021*
FREE WEBINAR: THE DTC·OS: EMPOWER THE PATIENT TRIAL EXPERIENCE Jun 24, 2021 - Jun 24, 2021SEPTEMBER 2021
*
PHARMA JAPAN
Sep 14, 2021 - Sep 16, 2021 Digital Conference, Exhibition & Networking*
CELL & GENE THERAPY
Sep 28, 2021 - Sep 29, 2021 Digital Conference, Exhibition & NetworkingOCTOBER 2021
*
REUTERS IMPACT
Oct 4, 2021 - Oct 7, 2021 Virtual Conference, Networking & Exhibition*
PHARMA EUROPE (FORMERLY EYEFORPHARMA BARCELONA) Oct 12, 2021 - Oct 22, 2021 Digital Conference, Exhibition & NetworkingNOVEMBER 2021
*
PHARMA & PATIENT USA Nov 2, 2021 - Nov 4, 2021 Digital Conference, Exhibition & Networking*
PHARMA MARKETING USA Nov 9, 2021 - Nov 11, 2021 Digital Conference, Exhibition & Networking*
TOTAL HEALTH USA
Nov 16, 2021 - Nov 17, 2021 Digital Conference, Exhibition & NetworkingIN-DEPTH ANALYSIS
*
Defragmenting Data for the Future of Pharma R&D*
Pharma’s Transformation through Automation*
Digital Therapeutics: pharma’s threat or opportunity*
Agility: How Pharma Can Be Bolder, Faster, Better*
Authenticity: Pharma’s New Currency*
Trends in Access Europe RECENT PRESS RELEASES*
eyeforpharma, a division of Reuters Events, announces eyeforpharma Philadelphia 2020 is now a virtual event*
Where pharma comes to life: Join 2000+ attendees at eyeforpharmaBarcelona 2020
*
eyeforpharma Philadelphia 2020: Become healthcare's solution*
UCB, Teva, Novartis, Pfizer and TransCelerate Biopharma win industry recognition the eyeforpharma Philadelphia Awards 2016.More Press Releases
Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales:2505735.
Reuters Events 2021 | TERMS OF USE| PRIVACY POLICY
| +44 (0)
207 375 7222
Follow
Hide
Follow on Twitter
Follow on LinkedIn
Follow on YouTube
YouTube
Follow on RSS
RSS
Show
Close
AddThis
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0